Published October 6, 2015
| Version v1
Patent
Open
Role of ADAM10 and its relevance to disease and therapeutics
Contributors
Patent applicants:
Description
Certain embodiments are directed to compositions and methods of inhibiting pathogenic bacterial infection involving ADAMIO comprising administering an effective amount of a metalloprotease inhibitor to a patient. Certain embodiments are directed to method of inhibiting Staphylococcal infection comprising administering an effective amount of a metalloprotease inhibitor to a patient. Other embodiments concern methods of inhibiting infection by a bacteria from the genus Clostridium, Streptococcus, Listeria, Bacillus, or Arcanobacterium.
Files
US9150865.pdf
Files
(2.5 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:6860aad339ff8d64e8fbbad274bf5e65
|
2.5 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201113884502 A
- Patent application number
- US 9150865 B2
- Other
- oai:uchicago.tind.io:8291
Dates
- Patent filed
-
2011-11-09